01Role and principlesWho benefits and the main preventive aims.
Obesity is a chronic, relapsing condition shaped by neuroendocrine regulation, genetics, medicines, environment, social determinants and behaviour. A respectful consultation improves disclosure and follow-up; moral judgement does not. Begin by asking whether weight is a topic the person wants to address today and whether being weighed is acceptable and safe.
Assessment has two linked aims: estimate adiposity-related risk and identify what is already affecting health. BMI categories help population decisions, while waist distribution, comorbidity and function refine individual risk. Muscular people, frail older adults, people with oedema, pregnancy and some disabilities need interpretation outside a mechanical BMI label.
A behavioural programme should create a feasible energy deficit without nutritional inadequacy, support movement within pain and disability limits, and build routines that can persist after intensive contact ends. No single named diet is universally superior. Cultural food patterns, finances, cooking access, caring duties, medication, sleep and the risk of eating-disorder relapse determine what is safe and sustainable.
Key points
- Ask permission to discuss weight, use the person's preferred language and offer a private, accessible weighing environment with suitable calibrated equipment.
- BMI is a screening measure, not a direct measure of individual health, muscle, fat distribution, disability, ethnicity, pregnancy or lived experience.
- For adults with BMI below 35, waist-to-height ratio can add central-adiposity information; a waist less than half height is a simple population message.
- NICE advises lower BMI thresholds, usually by 2.5 kg/m², when assessing intervention eligibility for several ethnic groups who develop cardiometabolic risk at lower BMI.
- Assess consequences systematically: type 2 diabetes, blood pressure, lipids, cardiovascular disease, sleep apnoea, fatty-liver risk, osteoarthritis, reproductive health and mental wellbeing.
- Look for medicine-related weight gain, sleep disruption, food insecurity, pain, shift work, menopause, neurodivergence, disability and disordered eating before prescribing a generic plan.
- Routine endocrine screening beyond clinically indicated thyroid or cortisol assessment has low yield; targeted clues should drive secondary-cause testing.
- Behavioural treatment works best as an individualised package covering dietary quality and energy balance, activity, sleep, self-monitoring, problem-solving and social context.
- Set goals beyond kilograms, such as walking tolerance, glycaemia, blood pressure, sleep, pain, fertility planning and quality of life.
- Expect plateaux and relapse because weight regulation is biological and environmental; review the plan without blame and escalate to medicines or surgery when indicated.
02Assessment and patient selectionRisk features, eligibility and important cautions.
A high waist-to-height ratio suggests visceral fat and cardiometabolic risk even when BMI is below an obesity threshold; use it as an additional conversation, not a diagnosis of character.
Raised blood pressure, dysglycaemia, atherogenic lipids or steatotic-liver risk increases treatment priority and may improve with modest sustained loss, independent of reaching a culturally idealised weight.
Loud snoring, witnessed apnoeas, morning headache, unrefreshing sleep and daytime somnolence suggest obstructive sleep apnoea; awake hypoxaemia, hypercapnia or somnolence can indicate obesity hypoventilation.
Cushingoid bruising and proximal weakness, hypothyroid symptoms, hypothalamic injury, rapid unexplained change or hypogonadal features justify targeted endocrine evaluation rather than a routine universal hormone panel.
Binge episodes, purging, severe restriction, compulsive exercise, night eating, body-image distress or previous eating-disorder treatment should alter the intervention and may require specialist mental-health or dietetic care.
Avoidance of care, previous humiliating encounters, poorly fitting equipment and every symptom being attributed to weight are clinically important barriers; acknowledge them and investigate new symptoms on their merits.
03Baseline assessmentMeasurements that guide the plan and track progress.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Weight, height and BMIFirst step - Why
- Provide a reproducible baseline for population risk and treatment eligibility.
- Interpretation and limitations
- Classify using adult thresholds while documenting situations that distort BMI; apply NICE's lower intervention thresholds for relevant ethnic backgrounds without changing how the person is respected.
- 02
Waist circumference and waist-to-height ratio - Why
- Estimate central adiposity when BMI alone may understate cardiometabolic risk.
- Interpretation and limitations
- For most adults with BMI below 35, waist at least half height indicates increased central risk; measurement adds less at very high BMI and must be performed consistently.
- 03
Blood pressure and cardiovascular assessment - Why
- Detect a common treatable complication and immediate vascular risk.
- Interpretation and limitations
- Confirm raised clinic readings through the NICE hypertension pathway; symptoms or severe pressure with organ injury require urgent assessment, not delayed lifestyle-only care.
- 04
HbA1c or fasting plasma glucose - Why
- Identify prediabetes, type 2 diabetes or marked hyperglycaemia.
- Interpretation and limitations
- Interpret using NICE diagnostic pathways and symptoms; very high glucose, ketones, dehydration or weight loss may indicate acute metabolic decompensation despite a high baseline weight.
- 05
Non-fasting lipid profile - Why
- Quantify atherosclerotic risk and screen severe triglyceride elevation.
- Interpretation and limitations
- Use total, HDL, non-HDL and triglycerides with overall cardiovascular risk; very high triglycerides need repeat fasting and urgent specialist logic rather than routine lifestyle review alone.
- 06
Liver blood tests and steatotic-liver fibrosis pathway - Why
- Identify liver injury and people needing fibrosis risk assessment.
- Interpretation and limitations
- Normal transaminases do not exclude steatotic liver or fibrosis. Follow the local MASLD pathway rather than using one ALT result as reassurance.
- 07
Targeted TSH, cortisol or reproductive testing - Why
- Investigate specific clinical evidence of endocrine or reproductive disease.
- Interpretation and limitations
- Request tests when symptoms and examination support them; indiscriminate cortisol panels and ovarian imaging can create false diagnoses without improving obesity care.
- 08
Validated sleep-apnoea assessment and oximetry pathway - Why
- Triage symptoms toward respiratory sleep testing and treatment.
- Interpretation and limitations
- A questionnaire estimates probability but does not diagnose OSA; suspected awake hypoventilation needs blood gas and specialist respiratory assessment.
04InterventionsLifestyle, treatment and escalation options.
01First conversationOpen a respectful assessmentFirst stepWeight or central adiposity may be contributing to current health concerns.+
- 1Ask permission, agree neutral language, provide privacy and accessible equipment, and establish what the person hopes will improve rather than imposing a target.
- 2Measure BMI and central adiposity where useful, then assess medical complications, medicines, sleep, mental health, eating pattern, mobility and socioeconomic constraints.
- 3Share risk in plain language, agree whether the focus is prevention, symptom relief or disease treatment, and document options including no immediate weight-loss intervention.
02Behavioural planBuild a multicomponent interventionThe person chooses active non-pharmacological weight management.+
- 1Co-design nutritionally complete changes that create a tolerable energy deficit and fit culture, budget, cooking access, work pattern and any eating-disorder risk.
- 2Increase physical activity and reduce sedentary time from the person's current ability, using physiotherapy or adapted exercise when pain, disability or cardiorespiratory disease limits movement.
- 3Add sleep, stress, self-monitoring, problem-solving and social support, then schedule regular review with pre-agreed functional, metabolic and weight-related outcomes.
03Plateau or regainReview without blameWeight loss plateaus, weight returns or the first plan proves unsustainable.+
- 1Reassess hunger, adherence burden, depression, binge eating, sleep, pain, new medicines, life events and whether the programme was realistically accessible.
- 2Preserve beneficial routines and cardiometabolic gains, then adjust intensity, dietetic support, activity adaptation or psychological intervention rather than prescribing shame.
- 3Discuss eligibility for licensed anti-obesity medicine or bariatric assessment through current NICE and local commissioning pathways when behavioural support alone is insufficient.
04Complex riskEscalate multidisciplinary careEscalationSevere comorbidity, safeguarding, disordered eating or complex disability limits routine management.+
- 1Treat urgent respiratory, cardiovascular, glycaemic or psychiatric risk first and make reasonable adjustments so diagnostic care is not withheld because of size.
- 2Coordinate obesity medicine, dietetics, psychology, physiotherapy, respiratory, hepatology, diabetes or reproductive teams according to the complications actually present.
- 3Agree one accountable follow-up plan, including medicine review and crisis contacts, so multiple referrals do not leave the person without active care.
05Targets, monitoring and follow-upResponse, safety and longer-term review.
- Use an agreed weighing frequency that informs care without reinforcing compulsive checking or shame; some people prefer functional and metabolic markers.
- Review blood pressure, glycaemia, lipids, liver-risk pathway and sleep symptoms according to baseline abnormalities rather than repeating every test at each visit.
- Track diet quality, protein and micronutrient adequacy when energy intake falls substantially, particularly in older adults and after previous bariatric surgery.
- Screen for binge eating, restrictive compensation, low mood and suicidality when the intervention or body-image focus appears to worsen mental wellbeing.
- Review medicines that promote weight gain and adjust only when the original indication, withdrawal risk and an effective alternative have been considered.
- At maintenance visits, plan for relapse triggers, preserve physical activity and sleep routines, and offer prompt re-entry rather than requiring a new failure threshold.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Permission changes the consultation
Asking whether now is a good time to discuss weight restores agency and often yields more honest information than beginning with an unsolicited instruction.
BMI needs a companion
Waist distribution, metabolic health, function and ethnicity can move risk in either direction, so a single ratio should open assessment rather than close it.
Health gains precede ideal weight
Small sustained changes can improve glycaemia, blood pressure, mobility and sleep; an unreachable cosmetic target can obscure meaningful clinical benefit.
Plateaux are biological
Energy expenditure and appetite adapt during loss. A plateau is a predictable treatment phase that prompts maintenance or escalation, not proof of dishonesty.
Equipment is patient safety
Suitable cuffs, scales, chairs, gowns, imaging limits and transfer aids are reasonable clinical requirements; missing equipment can delay diagnoses unrelated to obesity.
07Common pitfallsFrequent interpretation and management errors.
- 01
Starting a sensitive weight conversation without permission or privacy.
- 02
Using BMI as a verdict on individual behaviour or health.
- 03
Attributing dyspnoea, pain or menstrual change to weight without ordinary diagnostic assessment.
- 04
Prescribing a restrictive diet without screening for binge eating, malnutrition risk or food insecurity.
- 05
Offering activity advice that ignores pain, disability, safety and current capacity.
- 06
Repeating broad endocrine tests without clinical clues while missing sleep apnoea or medicines.
- 07
Defining success only by scale change and abandoning cardiometabolic or functional gains.
- 08
Treating regain as non-compliance rather than expected chronic-disease recurrence.